LAST week Pharmacy Daily reported on the rapidly approaching end of the transitional arrangement for the use of Electronic National Residential Medication Charts (eNRMC), with systems that are non-conformant no longer able to be used for prescriptions after 21 Oct (PD 03 Oct).

Telstra Health’s MedPoint was one of the non-conformant systems, and their response to PD’s request for comment came after it went to press.

The response confirmed the timeline reported in the article, and added:

“We understand customers feel let down and we have sincerely apologised for the administrative burden and disruption this has caused.

“We are working closely with customers to assist over this period and have provided interim workflow recommendations, including suggestions on how to manage these changes with prescribers and pharmacists until MedPoint conformance is achieved.

“Telstra Health remains fully committed to providing compliant, high-quality, clinically safe medication management solutions for our customers.”

Telstra Health confirmed its other products were not affected and that it will provide MedPoint customers with regular updates.

The post Telstra Health responds appeared first on Pharmacy Daily.